Skip to main content

Peer Review reports

From: Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study

Original Submission
7 Jun 2007 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Author responded Author comments
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
31 Mar 2008 Editorially accepted
31 Mar 2008 Article published 10.1186/1472-6904-8-2

You can find further information about peer review here.

Back to article page